Managing the Mental Distress of the Hematopoietic Stem Cell Transplant (HSCT) Patient: a Focus on Delirium
- 84 Downloads
Purpose of Review
To highlight the breadth and types of mental distress experienced by hematopoietic stem cell transplant (HSCT) patients and highlight the need for better prevention and management of delirium.
Recent publications highlight additional risks factors which predict for mental distress during the HSCT process. Despite new medications and additional psychological reports, there is little progress in non-pharmacologic or medication therapy in the prevention and treatment of delirium.
Mental distress, especially delirium, is common during the HSCT process. The morbidity associated with delirium and other mental distress can still be significant at 6–12 months after the completion of the procedure affecting patient functioning and quality of life (QOL). Medication interventions may be helpful but should be used sparingly for targeted patients during HSCT. Additional interventions are needed to prevent and treat delirium in HSCT patients.
KeywordsHematopoietic stem cell transplantation Mental distress Delirium
Compliance with Ethical Standards
Conflict of Interest
The author declares that he has no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by the author.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.• LeBlanc TW. Advance care planning and palliative care specialists in malignant hematology and stem-cell transplantation: on why it takes a village. J Oncol Pract. 2017;1–3. https://doi.org/10.1200/JOP.2017.026930; published online ahead of print. Recent editorial highlighting the complexities of HSCT with insightful comments on the need for a multidisciplinary team.
- 2.•• El-Jawhri A, Traeger L, Greer JA, et al. Effect of inpatient palliative care during hematopoietic-stem-cell transplant on psychological distress 6 months after transplant: results of a randomized clinical trial. J Clin Oncol. 2017;35:1–8. https://doi.org/10.1200/JCO.2017.73.2800. published online ahead of print. Small trial, but likely practice changing in the use of palliative care support during the peri-transplant period. Despite not reporting on delirium their impact on mental distress is promising. Google Scholar
- 3.Hefner J, Kapp M, Drebinger K, et al. High prevalence of distress in patients after allogeneic hematopoietic SCT: fear of progression is associated with a younger age. BMT. 2014;49:581–4.Google Scholar
- 11.Basinski JR, Alfano CM, Katon WJ, et al. Impact of delirium on distress, health-related quality of life, and cognition 6 months and 1 year after hematopoietic cell transplant. BBMT. 2010;16:824–31.Google Scholar
- 13.Beglinger LJ, Duff K, Van Der Heiden S, et al. Incidence of delirium and associated mortality in hematopoietic stem cell transplantation patients. BBMT. 2006;12:928–35.Google Scholar
- 14.El-Jawhri A, Chen YB, Brazauskas R. et al. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation Cancer 2017;000. https://doi.org/10.1002/cncr-30546. Published on line.
- 15.• Teale EA, Siddiqi N, Clegg A, et al. Non-pharmacological interventions for managing delirium in hospitalized patients. Cochrane Rev Protoc. 2017;(4):CD005995, 1–9. Proposed protocol for management of HSCT patient delirium risk. Requires validation but could serve as an interim model. Google Scholar
- 17.• Oh ES, Fong TG, Hshieh TT, Inouye SK. Delirium in older persons: advances in diagnosis and treatment. JAMA. 2017;318(12):1161–74. https://doi.org/10.1001/jama.2017.12067. Recent overview of delirium in the elderly highlighting the current state of care in delirious patients. Most of this information is informative to elderly HSCT patients even if not undergoing a myeloablative procedure. CrossRefPubMedGoogle Scholar
- 18.Lonergan E, Britton AM, Luxenberg J. Antipsychotics for delirium. Cochrane Database of Systematic Reviews. 2007;(2):CD005594, 1–17.Google Scholar